MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

A

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Search

Stevanato Group SpA

Fechado

SetorSaúde

20.18 -1.37

Visão Geral

Variação de preço das ações

24h

Atual

Mín

19.8

Máximo

20.53

Indicadores-chave

By Trading Economics

Rendimento

10M

49M

Vendas

23M

303M

P/E

Médio do Setor

34.417

88.032

EPS

0.162

Rendimento de Dividendos

0.26

Margem de lucro

16.205

Funcionários

5,521

EBITDA

10M

73M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+30.75% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.26%

2.26%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.1B

5.6B

Abertura anterior

21.55

Fecho anterior

20.18

Sentimento de Notícias

By Acuity

50%

50%

157 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de dez. de 2025, 22:20 UTC

Grandes Movimentos do Mercado

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 de dez. de 2025, 17:31 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 de dez. de 2025, 16:30 UTC

Grandes Movimentos do Mercado

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 de dez. de 2025, 15:19 UTC

Grandes Movimentos do Mercado

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 de dez. de 2025, 15:17 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 de dez. de 2025, 14:37 UTC

Grandes Movimentos do Mercado

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

31 de dez. de 2025, 21:13 UTC

Aquisições, Fusões, Aquisições de Empresas

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 de dez. de 2025, 20:40 UTC

Conversa de Mercado

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 de dez. de 2025, 20:22 UTC

Conversa de Mercado

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 de dez. de 2025, 19:50 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 de dez. de 2025, 19:31 UTC

Conversa de Mercado

Precious Metals Cap Off Record Runs -- Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

31 de dez. de 2025, 18:50 UTC

Conversa de Mercado

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 de dez. de 2025, 17:17 UTC

Conversa de Mercado

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 de dez. de 2025, 17:16 UTC

Grandes Movimentos do Mercado

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 de dez. de 2025, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

31 de dez. de 2025, 17:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 de dez. de 2025, 15:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 de dez. de 2025, 15:54 UTC

Conversa de Mercado

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 de dez. de 2025, 15:02 UTC

Grandes Movimentos do Mercado

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 de dez. de 2025, 14:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 de dez. de 2025, 14:20 UTC

Conversa de Mercado

Crude Futures On Track to End the Year With Losses -- Market Talk

31 de dez. de 2025, 13:46 UTC

Conversa de Mercado

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 de dez. de 2025, 13:01 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 de dez. de 2025, 11:10 UTC

Conversa de Mercado

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 de dez. de 2025, 10:46 UTC

Conversa de Mercado

Euro on Track For Strong Annual Performance -- Market Talk

31 de dez. de 2025, 10:25 UTC

Conversa de Mercado

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 de dez. de 2025, 10:23 UTC

Conversa de Mercado

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 de dez. de 2025, 09:33 UTC

Conversa de Mercado

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

30.75% parte superior

Previsão para 12 meses

Média 27 USD  30.75%

Máximo 30 USD

Mínimo 24 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

157 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat